By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) 

245 First Street
Suite 1800
Cambridge  Massachusetts  02142  U.S.A.
Phone: 503-227-0554 Fax: 503-227-0751


SEARCH JOBS

Sarepta Therapeutics is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. The Company is primarily focused on rapidly advancing the development of its potentially disease-modifying DMD drug candidates, including its lead DMD product candidate, eteplirsen, designed to skip exon 51. Sarepta is also developing therapeutics for the treatment of rare, infectious and other diseases.

Formerly called Antivirals, Inc.

YEAR FOUNDED:

1980

LEADERSHIP:

CEO: Ed Kaye, M.D.

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email: avi@avibio.com
Ownership: Public

Web Site: Sarepta
Employees: 48
Symbol: SRPT
 



Industry
Biotechnology






Company News
Sarepta (SRPT) Announces Grand Opening Of Its Research And Manufacturing Center At Andover 6/27/2017 8:09:57 AM
Sarepta (SRPT) And Genethon Announce A Gene Therapy Research Collaboration For The Treatment Of Duchenne Muscular Dystrophy 6/21/2017 7:40:08 AM
Sarepta (SRPT) Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 6/1/2017 12:41:16 PM
Journalist Sues FDA for Documents Related to Sarepta (SRPT)'s DMD Drug 5/26/2017 6:22:15 AM
Can Sarepta (SRPT) Continue To Live Up To The DMD Hype? 5/8/2017 6:36:32 AM
Sarepta (SRPT) Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 5/2/2017 11:57:43 AM
Sarepta (SRPT) Tests Biotech's CEO Vacuum Hypothesis 5/2/2017 6:11:09 AM
How Much Rumored Suitors Like Sanofi (SNY) Would Have To Pay For Sarepta (SRPT) 5/2/2017 6:10:29 AM
Why M&A Hungry Sanofi (SNY) Could be Gearing Up to Buy Sarepta (SRPT) 5/1/2017 6:09:23 AM
Here's Why Sarepta (SRPT) May Be The Rarest Of Finds: A 'Value' Biotech Stock 5/1/2017 5:48:09 AM
12345678910...
//-->